Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)

Clinical trial NCT07221565 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07221565
Sponsor: Truway Health, Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Rheumatoid Arthritis Multiple Sclerosis Autoimmune Diseases Chronic Inflammatory Syndromes Immune Dysregulation

Start date: 2025-10-23
Primary completion: 2034-10-23
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.